Ju Du
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Neurology top 5%
- Barrier Structure and Function Studies
Papers in
-
- Nanoparticle-Based Drug Delivery 5
-
- Inhalation and Respiratory Drug Delivery 7
- Renal cell carcinoma treatment 1
- Co-authors
- Wan-Liang Lü (7 shared papers)Jinning Lou (4 shared papers)Xue Ying (4 shared papers)Hugh D. C. Smyth (6 shared papers)Ruo‐Jing Li (3 shared papers)Wei Jun Tian (3 shared papers)Qiang Zhang (2 shared papers)Xinru Jia (1 shared paper)
- Journals
- Molecular Pharmaceutics (2 papers)AAPS PharmSciTech (2 papers)Journal of Controlled Release (2 papers)European Journal of Pharmaceutics and Biopharmaceutics (2 papers)Canadian Journal of Physiology and Pharmacology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ju Du
17 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 60
- Biomaterials 690
- Neurology 149
- Pharmaceutical Science 76
- Polymers and Plastics 125
- Drug Discovery 2
Countries citing papers authored by Ju Du
This map shows the geographic impact of Ju Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju Du more than expected).
Fields of papers citing papers by Ju Du
This network shows the impact of papers produced by Ju Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju Du. The network helps show where Ju Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Ju Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 407 | |
| 2 | 2010 | 278 | |
| 3 | 2009 | 138 | |
| 4 | 2008 | 109 | |
| 5 | 2012 | 62 | |
| 6 | 2015 | 60 | |
| 7 | 2010 | 59 | |
| 8 | 2014 | 47 | |
| 9 | 2014 | 31 | |
| 10 | 2016 | 24 | |
| 11 | 2015 | 19 | |
| 12 | 2013 | 18 | |
| 13 | 2024 | 13 | |
| 14 | 2008 | 10 | |
| 15 | 2015 | 9 | |
| 16 | [Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma]. | 2015 | 3 |
| 17 | 2008 | 2 |
About Ju Du
Ju Du is a scholar working on Biomaterials, Pulmonary and Respiratory Medicine, Polymers and Plastics, Oncology and Molecular Biology, having authored 17 papers that have together received 1.3k indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (7 papers), Nanoparticle-Based Drug Delivery (5 papers), Bacterial biofilms and quorum sensing (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Dendrimers and Hyperbranched Polymers (1 paper), Chemokine receptors and signaling (1 paper), Nanoplatforms for cancer theranostics (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Biomaterials (690 citations), Neurology (149 citations), Pharmaceutical Science (76 citations), Polymers and Plastics (125 citations) and Drug Discovery (2 citations). Ju Du has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Wan-Liang Lü, Jinning Lou, Xue Ying, Hugh D. C. Smyth, Ruo‐Jing Li, Wei Jun Tian, Qiang Zhang, Xinru Jia, Hai He and Yan Li. Their work appears in journals such as Molecular Pharmaceutics, AAPS PharmSciTech, Journal of Controlled Release, European Journal of Pharmaceutics and Biopharmaceutics and Canadian Journal of Physiology and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.